| ReFacto AF 1000 IU powder and solvent for solution for injection EU/1/99/103/003 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 1000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/007 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection EU/1/99/103/004 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/008 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 250 IU powder and solvent for solution for injection EU/1/99/103/001 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/005 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection EU/1/99/103/002 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/006 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| Refixia 1 000 IU powder and solvent for solution for injection EU/1/17/1193/002 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 2 000 IU powder and solvent for solution for injection EU/1/17/1193/003 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 3 000 IU powder and solvent for solution for injection EU/1/17/1193/004 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 500 IU powder and solvent for solution for injection EU/1/17/1193/001 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| REKAMBYS 600 mg prolonged-release suspension for injection EU/1/20/1482/001 |
Rilpivirine |
Janssen-Cilag International NV |
— |
| REKAMBYS 900 mg prolonged-release suspension for injection EU/1/20/1482/002 |
Rilpivirine |
Janssen-Cilag International NV |
— |
| REKOVELLE 12 micrograms/0.36 mL solution for injection in a pre-filled pen EU/1/16/1150/004 |
Follitropin delta |
Ferring Pharmaceuticals A/S |
— |
| REKOVELLE 36 micrograms/1.08 mL solution for injection in a pre-filled pen EU/1/16/1150/005 |
Follitropin delta |
Ferring Pharmaceuticals A/S |
— |
| Rekovelle 72 micrograms/2.16 mL solution for injection in a pre-filled pen EU/1/16/1150/006 |
Follitropin delta |
Ferring Pharmaceuticals A/S |
— |
| Relistor EU/1/08/463/004-008 |
Methylnaltrexone bromide |
Bausch Health Ireland Limited |
— |
| Relistor EU/1/08/463/8-11 |
Methylnaltrexone bromide |
Bausch Health Ireland Limited |
— |
| RELISTOR 12 mg/0.6 mL solution for injection EU/1/08/463/1-3 |
Methylnaltrexone bromide |
Bausch Health Ireland Limited |
— |
| Relvar Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/13/886/004-006 |
Fluticasone furoate, Vilanterol trifenatate micronised |
GlaxoSmithKline (Ireland) Limited |
— |
| Relvar Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/13/886/001-003 |
Fluticasone furoate, Vilanterol trifenatate micronised |
GlaxoSmithKline (Ireland) Limited |
— |
| Remicade 100 mg Powder for concentrate for solution for infusion EU/1/99/116/001-5 |
Infliximab |
Janssen-Cilag International NV |
— |
| Remifentanil 1 mg powder for concentrate for solution for injection or infusion PA2059/056/001 |
Remifentanil |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Remifentanil 2 mg powder for concentrate for solution for injection or infusion PA2059/056/002 |
Remifentanil |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Remifentanil 5 mg powder for concentrate for solution for injection or infusion PA2059/056/003 |
Remifentanil |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Remsima 100 mg powder for concentrate for solution for infusion EU/1/13/853/001 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |
| Remsima 120 mg solution for injection in pre-filled pen EU/1/13/853/012-014 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |
| Remsima 120 mg solution for injection in pre-filled syringe EU/1/13/853/006-011 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |
| Remsima 40 mg/mL concentrate for solution for infusion EU/1/13/853/018-027 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |
| Renagel EU/1/99/123/006 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/007 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/009 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/010 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/011-013 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel 400 mg Film-coated tablet EU/1/99/123/005-007 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel 800 mg Film-coated tablet EU/1/99/123/008-013 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| RENOCIS 1 mg kit for radiopharmaceutical preparation PA0677/005/001 |
Succimer |
CIS bio International |
Marketed |
| Renvela 0.8 g Powder for oral suspension EU/1/09/521/008-009 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 0.8 g Powder for oral suspension (with dosing spoon) EU/1/09/521/009 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 1.6 g Powder for oral suspension EU/1/09/521/4-5 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 2.4 g Powder for oral suspension EU/1/09/521/6-7 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 800 mg Film-coated tablet EU/1/09/521/1-3 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Repaglinide Accord 0.5 mg tablets EU/1/11/743/001-005 |
Repaglinide |
Accord Healthcare S.L.U. |
— |
| Repaglinide Accord 1 mg tablets EU/1/11/743/006-010 |
Repaglinide |
Accord Healthcare S.L.U. |
— |
| Repaglinide Accord 2 mg tablets EU/1/11/743/011-015 |
Repaglinide |
Accord Healthcare S.L.U. |
— |
| Repaglinide Krka 0.5 mg tablets EU/1/09/579/1-6 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Krka 1 mg tablets EU/1/09/579/7-12 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Krka 2 mg tablets EU/1/09/579/13-18 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Teva 0.5 mg Tablet EU/1/09/530/1-5 |
Repaglinide |
Teva Pharma B.V. |
— |